Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Physostigmine in tricyclic antidepressant overdose

P B Johnson

    JACEP
    |June 1, 1976
    PubMed
    Summary

    Physostigmine salicylate effectively reverses anticholinergic syndrome from tricyclic antidepressant overdose. This rapid-acting antidote requires careful monitoring due to its short duration, potentially necessitating repeated doses for sustained effect.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    An Account of the Beneficial Effects of Ergot in a Case of Hydatids of the Uterus.

    The Western journal of the medical and physical sciences·2023
    Same author

    Re: variants of hepatic arterial supply in a Caribbean population: a computed tomography based study. A reply.

    Clinical radiology·2013
    Same author

    Variants of hepatic arterial supply in a Caribbean population: a computed tomography based study.

    Clinical radiology·2013
    Same author

    Electron beam annealing of Fe+ implanted Si nanostructures.

    Journal of nanoscience and nanotechnology·2010
    Same author

    Selective laser trabeculoplasty: predictive value of early intraocular pressure measurements for success at 3 months.

    The British journal of ophthalmology·2006
    Same author

    Gender, weight concerns, and adolescent smoking.

    Journal of addictive diseases·2001

    Area of Science:

    • Emergency Medicine
    • Clinical Toxicology
    • Pharmacology

    Background:

    • Anticholinergic syndrome is a serious complication of tricyclic antidepressant (TCA) overdose.
    • Current emergency medicine protocols seek effective antidotes for TCA toxicity.
    • Physostigmine salicylate is a unique parasympathomimetic agent with potential to reverse anticholinergic effects.

    Observation:

    • Physostigmine salicylate rapidly reverses central and peripheral manifestations of anticholinergic syndrome.
    • Onset of action is typically within 5 to 20 minutes following administration.
    • The drug's short duration of action may lead to recurrent intoxication.

    Findings:

    • Four cases of successful management of TCA overdose using physostigmine salicylate are presented.
    • The study reviews pertinent literature on physostigmine's efficacy and use in TCA poisoning.
    • Repeated dosing of physostigmine may be required to manage prolonged toxic effects.

    Implications:

    • Physostigmine salicylate is a critical therapeutic option for managing severe anticholinergic toxicity.
    • Understanding its pharmacokinetic profile is essential for optimal patient management.
    • Further research may explore strategies to prolong physostigmine's therapeutic effect or manage recurrence.

    Related Experiment Videos